A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Van der Lee SJ et al,

Journal title: Acta Neuropathologica

Journal publisher: Springer Verlag

Published year: 2019

DOI identifier: 10.1007/s00401-019-02026-8

ISSN: 0001-6322